Literature DB >> 11118353

p29, a novel GCIP-interacting protein, localizes in the nucleus.

M S Chang1, C L Chang, C J Huang, Y C Yang.   

Abstract

GCIP, a newly identified cyclin D-interacting protein, was found to reduce the phosphorylation of retinoblastoma protein and inhibit E2F1-mediated transcriptional activity. To explore more GCIP interacting proteins, the yeast two-hybrid screening using GCIP as a bait protein was performed. One novel gene, p29, was demonstrated to associate with GCIP in the yeast two-hybrid method and in vitro GST pull-down assay. Multiple tissue Northern blot analysis showed that p29 was abundantly expressed in the heart, skeletal muscle, and kidney relative to other tissues. The transient expression of HA-tagged p29 in HeLa cells localized in the nucleus. Taken together, we have isolated a novel protein, p29, which may be involved in the functional regulation of GCIP. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118353     DOI: 10.1006/bbrc.2000.3992

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  SYF2 is upregulated in human epithelial ovarian cancer and promotes cell proliferation.

Authors:  Sujuan Yan; Yan Deng; Yong Qiang; Qinghua Xi; Rong Liu; Shuyun Yang; Jian Liu; Chunhui Tang; Jianxin Zhong; Yingying Wang
Journal:  Tumour Biol       Date:  2015-01-28

2.  Knocking down the expression of SYF2 inhibits the proliferation of glioma cells.

Authors:  Jun Guo; Lixiang Yang; Jianfeng Huang; Xiancheng Liu; Xiaojun Qiu; Tao Tao; Yonghua Liu; Xiaojuan He; Na Ban; Shaochen Fan; Guan Sun
Journal:  Med Oncol       Date:  2014-07-02       Impact factor: 3.064

3.  Upregulation of SYF2 Relates to Retinal Ganglion Cell Apoptosis and Retinal Glia Cell Proliferation After Light-Induced Retinal Damage.

Authors:  Aimin Sang; Xiaowei Yang; Hui Chen; Bai Qin; Manhui Zhu; Ming Dai; Rongrong Zhu; Xiaojuan Liu
Journal:  J Mol Neurosci       Date:  2015-05-06       Impact factor: 3.444

4.  Elucidation of stannin function using microarray analysis: implications for cell cycle control.

Authors:  Brian E Reese; Dan Krissinger; Jong K Yun; Melvin L Billingsley
Journal:  Gene Expr       Date:  2006

5.  Simple decision rules for classifying human cancers from gene expression profiles.

Authors:  Aik Choon Tan; Daniel Q Naiman; Lei Xu; Raimond L Winslow; Donald Geman
Journal:  Bioinformatics       Date:  2005-08-16       Impact factor: 6.937

6.  Gene expression during anthesis and senescence in Iris flowers.

Authors:  W G van Doorn; P A Balk; A M van Houwelingen; F A Hoeberichts; R D Hall; O Vorst; C van der Schoot; M F van Wordragen
Journal:  Plant Mol Biol       Date:  2003-12       Impact factor: 4.076

7.  Involvement of upregulated SYF2 in Schwann cell differentiation and migration after sciatic nerve crush.

Authors:  Zhengming Zhou; Yang Liu; Xiaoke Nie; Jianhua Cao; Xiaojian Zhu; Li Yao; Weidong Zhang; Jiang Yu; Gang Wu; Yonghua Liu; Huiguang Yang
Journal:  Cell Mol Neurobiol       Date:  2014-06-25       Impact factor: 5.046

8.  Upregulation of SYF2 in esophageal squamous cell carcinoma promotes tumor cell proliferation and predicts poor prognosis.

Authors:  Junya Zhu; Lili Ji; Jianguo Zhang; Lei Yang; Chengqi Guan; Yayun Wang; Jia Zhu; Li Liang; Runzhou Ni
Journal:  Tumour Biol       Date:  2014-07-18

9.  Knockdown of PFTK1 Inhibits the Migration of Glioma Cells.

Authors:  Shaochen Fan; Chengjin Zhao; Li Zhang; Shirong Dai; Jianbing Ren; Xiubing Zhang; Na Ban; Xiaojuan He; Lixiang Yang; Zhen Bao; Wenjuan Chen; Jie Sun; Yilu Gao; Tao Tao
Journal:  J Mol Neurosci       Date:  2015-08-04       Impact factor: 3.444

10.  Overexpression of SYF2 correlates with enhanced cell growth and poor prognosis in human hepatocellular carcinoma.

Authors:  Shusen Zhang; Weidong Shi; Yuyan Chen; Zhiwei Xu; Jia Zhu; Tingting Zhang; Wei Huang; Runzhou Ni; Cuihua Lu; Xiubing Zhang
Journal:  Mol Cell Biochem       Date:  2015-08-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.